The Centers for Medicare & Medicaid Services seeks input on rulemaking to require electronic prescribing for controlled substances covered by Medicare Part D and Medicare Advantage prescription drug plans beginning Jan. 1, in accordance with the Substance Use-Disorder Prevention that Promotes Opioid Recover and Treatment for Patients and Communities Act of 2018.

The request for information asks whether there should be exceptions to the requirement and under what circumstances, and whether CMS should impose penalties for noncompliance. Comments are due Oct. 3.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Friday released a toolkit for qualified health plans applying for plan year 2022 certification, and…
Headline
New information sharing requirements for health information technology take effect April 5 under an interim final rule released last year by the Office of the…
Headline
The Department of Homeland Security yesterday formally removed its public charge rule from the Code of Federal Regulations. The Biden administration this…
Headline
AHA today urged the Department of Health and Human Services’ Office for Civil Rights to take a holistic approach as it deliberates changes to the HIPAA Privacy…
Headline
The Department of Health and Human Services’ Office for Civil Rights today formally published in the Federal Register a proposed rule released Dec. 10 that…
Headline
The Department of Health and Human Services’ Office for Civil Rights will not impose penalties on covered health care providers, their business associates or…